Komplizierte frakturassoziierte Infektion bei einem ukrainischen Kriegsverletzten

Fabian Reinhardt; Stephan David

doi:10.1055/a-2280-2464

Flugmedizin · Tropenmedizin · Reisemedizin - FTR, Table of Contents

Flugmedizin · Tropenmedizin · Reisemedizin - FTR 2024; 31(02): 49-52
DOI: 10.1055/a-2280-2464

Kasuistik

Komplizierte frakturassoziierte Infektion bei einem ukrainischen Kriegsverletzten

Complicated fracture-associated infection in a Ukrainian war casualty

Fabian Reinhardt

¹Medizinische Klinik III, Evangelisches Krankenhaus Paul Gerhard Stift, Lutherstadt Wittenberg

,

Stephan David

²Klinik für Unfallchirurgie und Orthopädie, Evangelisches Krankenhaus Paul Gerhard Stift, Lutherstadt Wittenberg

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Bernard L, Arvieux C, Brunschweiler B. et al Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection. N Engl J Med 2021; 384: 1991-2001
2 European Centre for Disease Prevention and Control, World Health Organization. Antimicrobial resistance surveillance in Europe 2023: 2021 data. LU: Publications Office; 2023
3 Paul M, Carrara E, Retamar P. et al European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect 2022; 28: 521-547
4 Choby JE, Ozturk T, Satola SW. et al Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens. Lancet Infect Dis 2021; 21: 597-598
5 Bassetti M, Echols R, Matsunaga Y. et al Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis 2021; 21: 226-240
6 Beganovic M, Daffinee KE, Luther MK. et al Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model. Antimicrob Agents Chemother 2021; 65: e01680-20
7 Abdul-Mutakabbir JC, Yim J, Nguyen L. et al In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii. Antibiotics (Basel) 2021; 10: 880
8 Tamma PD, Aitken SL, Bonomo RA. et al Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis 2023: ciad428